OBJECTIVE: Our objective was to summarize and critically review data on the prevalence of posttraumatic stress disorder (PTSD) in general intensive care unit (ICU) survivors, risk factors for post-ICU PTSD and the impact of post-ICU PTSD on health-related quality of life (HRQOL). METHODS: We conducted a systematic literature review using Medline, EMBASE, Cochrane Library, CINAHL, PsycINFO and a hand-search of 13 journals. RESULTS: Fifteen studies were eligible. The median point prevalence of questionnaire-ascertained "clinically significant" PTSD symptoms was 22% (n=1,104), and the median point prevalence of clinician-diagnosed PTSD was 19% (n=93). Consistent predictors of post-ICU PTSD included prior psychopathology, greater ICU benzodiazepine administration and post-ICU memories of in-ICU frightening and/or psychotic experiences. Female sex and younger age were less consistent predictors, and severity of critical illness was consistently not a predictor. Post-ICU PTSD was associated with substantially lower HRQOL. CONCLUSIONS: The prevalence of PTSD in ICU survivors is high and negatively impacts survivors' HRQOL. Future studies should comprehensively address how patient-specific factors (e.g., pre-ICU psychopathology), ICU management factors (e.g., administration of sedatives) and ICU clinical factors (e.g., in-ICU delirium) relate to one another and to post-ICU PTSD. Clinicians caring for the growing population of ICU survivors should be aware of PTSD risk factors and monitor patients' needs for early intervention.
OBJECTIVE: Our objective was to summarize and critically review data on the prevalence of posttraumatic stress disorder (PTSD) in general intensive care unit (ICU) survivors, risk factors for post-ICU PTSD and the impact of post-ICU PTSD on health-related quality of life (HRQOL). METHODS: We conducted a systematic literature review using Medline, EMBASE, Cochrane Library, CINAHL, PsycINFO and a hand-search of 13 journals. RESULTS: Fifteen studies were eligible. The median point prevalence of questionnaire-ascertained "clinically significant" PTSD symptoms was 22% (n=1,104), and the median point prevalence of clinician-diagnosed PTSD was 19% (n=93). Consistent predictors of post-ICU PTSD included prior psychopathology, greater ICU benzodiazepine administration and post-ICU memories of in-ICU frightening and/or psychotic experiences. Female sex and younger age were less consistent predictors, and severity of critical illness was consistently not a predictor. Post-ICU PTSD was associated with substantially lower HRQOL. CONCLUSIONS: The prevalence of PTSD in ICU survivors is high and negatively impacts survivors' HRQOL. Future studies should comprehensively address how patient-specific factors (e.g., pre-ICU psychopathology), ICU management factors (e.g., administration of sedatives) and ICU clinical factors (e.g., in-ICU delirium) relate to one another and to post-ICU PTSD. Clinicians caring for the growing population of ICU survivors should be aware of PTSD risk factors and monitor patients' needs for early intervention.
Authors: Judith Jacobi; Gilles L Fraser; Douglas B Coursin; Richard R Riker; Dorrie Fontaine; Eric T Wittbrodt; Donald B Chalfin; Michael F Masica; H Scott Bjerke; William M Coplin; David W Crippen; Barry D Fuchs; Ruth M Kelleher; Paul E Marik; Stanley A Nasraway; Michael J Murray; William T Peruzzi; Philip D Lumb Journal: Crit Care Med Date: 2002-01 Impact factor: 7.598
Authors: G Schelling; J Briegel; B Roozendaal; C Stoll; H B Rothenhäusler; H P Kapfhammer Journal: Biol Psychiatry Date: 2001-12-15 Impact factor: 13.382
Authors: G Schelling; C Stoll; H P Kapfhammer; H B Rothenhäusler; T Krauseneck; K Durst; M Haller; J Briegel Journal: Crit Care Med Date: 1999-12 Impact factor: 7.598
Authors: D L Musselman; A H Miller; M R Porter; A Manatunga; F Gao; S Penna; B D Pearce; J Landry; S Glover; J S McDaniel; C B Nemeroff Journal: Am J Psychiatry Date: 2001-08 Impact factor: 18.112
Authors: JiYeon Choi; Jennifer H Lingler; Michael P Donahoe; Mary Beth Happ; Leslie A Hoffman; Judith A Tate Journal: Heart Lung Date: 2018-05-03 Impact factor: 2.210
Authors: James C Jackson; Pratik P Pandharipande; Timothy D Girard; Nathan E Brummel; Jennifer L Thompson; Christopher G Hughes; Brenda T Pun; Eduard E Vasilevskis; Alessandro Morandi; Ayumi K Shintani; Ramona O Hopkins; Gordon R Bernard; Robert S Dittus; E Wesley Ely Journal: Lancet Respir Med Date: 2014-04-07 Impact factor: 30.700
Authors: Robert Y Lee; Lyndia C Brumback; Seelwan Sathitratanacheewin; William B Lober; Matthew E Modes; Ylinne T Lynch; Corey I Ambrose; James Sibley; Kelly C Vranas; Donald R Sullivan; Ruth A Engelberg; J Randall Curtis; Erin K Kross Journal: JAMA Date: 2020-03-10 Impact factor: 56.272